Novo Nordisk Rules Out Higher Bid for Metsera as Pfizer Seals $86.25 per Share Deal
Novo Nordisk A/S (NYSE: NVO) confirmed today that it will not pursue an increased offer...
Novo Nordisk A/S (NYSE: NVO) confirmed today that it will not pursue an increased offer...
China‑based Chengdu Maxvax Biotechnology Co., Ltd. announced the successful completion of its Series D funding round,...
Novo Nordisk A/S (NYSE: NVO) announced today an unsolicited offer of USD 9 billion for Metsera, Inc....
Thermo Fisher Scientific Inc. (NYSE: TMO) announced a definitive agreement to acquire Clario Holdings, Inc., a...
PolyMed Biopharmaceuticals Co., Ltd., a Chinese‑based, internationally‑oriented biopharma innovator, announced the successful closure of its...
China‑based Hangzhou Tigermed Consulting Co., Ltd. (HKG: 3347) announced that it and its subsidiary Jiaxing...
China‑based TJ Biopharma announced today the successful completion of a Series C2 financing round that raised...
Full‑Life Technologies, a global radiotherapeutics integrator, announced today the successful completion of $77 million in financing,...
Sanofi (NASDAQ: SNY) announced today a new capital infusion of USD 625 million into its corporate venture...
Siemens Healthineers AG (ETR: SHL), a Germany-based medical device giant is reportedly in exploratory talks...
China‑based Baheal Pharmaceutical Group (SHE: 301015) announced a strategic cooperation agreement with Tianjin Jikun Pharmaceutical...
China‑based Qilu Pharmaceutical and the Foundation for the Development of Science and Technology in China (FDSTC),...
ChemPartner Pharmatech Co., Ltd. (SHE: 300149) announced that its wholly‑owned subsidiary, Beihai ChemPartner Venture Capital...
IVD Medical Holding Limited (HKG: 1931) disclosed that it will purchase 1,848,496,429 shares of GoFintech...
Nanjing‑based Minova Pharmaceuticals Co., Ltd. closed a Series B financing round worth hundreds of millions of...
On August 26, 2025, Hong Kong‑listed China-based InxMed (Nanjing) Co., Ltd (HKG: 2509) announced that it has...
Vibrant Therapeutics, an innovative biotech company specializing in next-generation intelligent macromolecule drugs, announced on August...
Tianjin Lisheng Pharmaceutical Co., Ltd. (SHE: 002393), based in China, announced plans to co-establish the...
Shanghai Haohai Biological Technology Co., Ltd. (HKG: 6826, SHA: 688366) announced the termination of its...
Biopharmaceutical company Vivatides Therapeutics has successfully completed a multi-million dollar seed round financing led by...